메뉴 건너뛰기




Volumn 42, Issue 2, 2008, Pages 130-133

Effect of tadalafil on anaerobic performance indices in healthy athletes

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; PLACEBO; TADALAFIL;

EID: 39449089792     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2007.037630     Document Type: Article
Times cited : (19)

References (30)
  • 1
    • 0037070232 scopus 로고    scopus 로고
    • Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: A randomised crossover trial
    • Arruda-Olson AM, Mahoney DW, Nehra A, et al. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomised crossover trial. JAMA 2002;287:719- 25.
    • (2002) JAMA , vol.287 , pp. 719-725
    • Arruda-Olson, A.M.1    Mahoney, D.W.2    Nehra, A.3
  • 2
    • 0346333034 scopus 로고    scopus 로고
    • Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease
    • DeBusk RF, Pepine CJ, Glasser DB, et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol 2004;93:147-53.
    • (2004) Am J Cardiol , vol.93 , pp. 147-153
    • DeBusk, R.F.1    Pepine, C.J.2    Glasser, D.B.3
  • 3
    • 3543120077 scopus 로고    scopus 로고
    • Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: A randomized, double-blind, placebo-controlled crossover trial
    • Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 2004;141:169-77.
    • (2004) Ann Intern Med , vol.141 , pp. 169-177
    • Ghofrani, H.A.1    Reichenberger, F.2    Kohstall, M.G.3
  • 5
    • 0242460582 scopus 로고    scopus 로고
    • Cardiovascular effects of tadalafil in patients on common antihypertensive therapies
    • Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol 2003;92:47-57M.
    • (2003) Am J Cardiol , vol.92
    • Kloner, R.A.1    Mitchell, M.2    Emmick, J.T.3
  • 6
    • 33744916246 scopus 로고    scopus 로고
    • Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia
    • Hsu AR, Barnholt KE, Grundmann NK, et al. Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. J Appl Physiol 2006;100:2031-40.
    • (2006) J Appl Physiol , vol.100 , pp. 2031-2040
    • Hsu, A.R.1    Barnholt, K.E.2    Grundmann, N.K.3
  • 7
    • 17344362498 scopus 로고    scopus 로고
    • Effects of sildenafil on the human response to acute hypoxia and exercise
    • Ricart A, Maristany J, Fort N, et al. Effects of sildenafil on the human response to acute hypoxia and exercise. High Alt Med Biol 2005;6:43-9.
    • (2005) High Alt Med Biol , vol.6 , pp. 43-49
    • Ricart, A.1    Maristany, J.2    Fort, N.3
  • 8
    • 0037183551 scopus 로고    scopus 로고
    • Sildenafil effects on exercise, neurohormonal activation and erectile dysfunction in congestive heart failure: A double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction
    • Bocchi EA, Guimaraes G, Mocelin A, et al. Sildenafil effects on exercise, neurohormonal activation and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation 2002;106:1097-103.
    • (2002) Circulation , vol.106 , pp. 1097-1103
    • Bocchi, E.A.1    Guimaraes, G.2    Mocelin, A.3
  • 9
    • 4644232338 scopus 로고    scopus 로고
    • Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study
    • Ghofrani HA, Voswinckel R, Reichenberger F, et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 2004;44:1488- 96.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1488-1496
    • Ghofrani, H.A.1    Voswinckel, R.2    Reichenberger, F.3
  • 10
    • 0033609027 scopus 로고    scopus 로고
    • Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure
    • Katz SD, Khan T, Zeballos GA, et al. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 1999;99:2113-17.
    • (1999) Circulation , vol.99 , pp. 2113-2117
    • Katz, S.D.1    Khan, T.2    Zeballos, G.A.3
  • 11
    • 0242349756 scopus 로고    scopus 로고
    • Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension
    • Michelakis ED, Tymchak W, Noga M, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003;108:2066-9.
    • (2003) Circulation , vol.108 , pp. 2066-2069
    • Michelakis, E.D.1    Tymchak, W.2    Noga, M.3
  • 12
    • 0034642329 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterase type 5 activity limits blood flow to hypoperfused myocardium during exercise
    • Traverse JH, Chen YJ, Du R, et al. Cyclic nucleotide phosphodiesterase type 5 activity limits blood flow to hypoperfused myocardium during exercise. Circulation 2000;102:2997-3002.
    • (2000) Circulation , vol.102 , pp. 2997-3002
    • Traverse, J.H.1    Chen2    YJ, D.R.3
  • 13
    • 0026327575 scopus 로고
    • Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues
    • Ahn HS, Foster M, Cable M, et al. Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues. Adv Exp Med Biol 1991;308:191-7.
    • (1991) Adv Exp Med Biol , vol.308 , pp. 191-197
    • Ahn, H.S.1    Foster, M.2    Cable, M.3
  • 14
    • 0242625934 scopus 로고    scopus 로고
    • An update on the PDE-5 inhibitors (PDE-5i)
    • McCullough AR. An update on the PDE-5 inhibitors (PDE-5i). J Androl 2003;24:S52-8.
    • (2003) J Androl , vol.24
    • McCullough, A.R.1
  • 15
    • 22644440012 scopus 로고    scopus 로고
    • 3,5-Cyclic nucleotide phosphodiesterase 11A: Localization in human tissues
    • Loughney K, Taylor J, Florio VA. 3,5-Cyclic nucleotide phosphodiesterase 11A: localization in human tissues. Int J Impot Res 2005;17:320-5.
    • (2005) Int J Impot Res , vol.17 , pp. 320-325
    • Loughney, K.1    Taylor, J.2    Florio, V.A.3
  • 16
    • 0030154874 scopus 로고    scopus 로고
    • Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
    • Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
    • (1996) Int J Impot Res , vol.8 , pp. 47-52
    • Boolell, M.1    Allen, M.J.2    Ballard, S.A.3
  • 17
    • 0034868820 scopus 로고    scopus 로고
    • The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at-home clinical trial
    • Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001;13:192-9.
    • (2001) Int J Impot Res , vol.13 , pp. 192-199
    • Porst, H.1    Rosen, R.2    Padma-Nathan, H.3
  • 18
    • 0036332629 scopus 로고    scopus 로고
    • Pharmacology of phosphodiesterase-5 inhibitors
    • Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract 2002;56:453-9.
    • (2002) Int J Clin Pract , vol.56 , pp. 453-459
    • Corbin, J.D.1    Francis, S.H.2
  • 19
    • 22244447089 scopus 로고    scopus 로고
    • Recreational use and misuse of phosphodiesterase 5 inhibitors
    • Smith KM, Romanelli F. Recreational use and misuse of phosphodiesterase 5 inhibitors. J Am Pharm Assoc 2005;45:63-72.
    • (2005) J Am Pharm Assoc , vol.45 , pp. 63-72
    • Smith, K.M.1    Romanelli, F.2
  • 20
    • 39449092563 scopus 로고    scopus 로고
    • max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med 2007; epub ahead of print.
    • max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med 2007; epub ahead of print.
  • 21
    • 0025249867 scopus 로고
    • Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure
    • Metra M, Raddino B, Dei Cas L, et al. Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure. Am J Cardiol 1990;65:1127-33.
    • (1990) Am J Cardiol , vol.65 , pp. 1127-1133
    • Metra, M.1    Raddino, B.2    Dei Cas, L.3
  • 23
    • 0036943348 scopus 로고    scopus 로고
    • How anaerobic is the Wingate Anaerobic Test for humans?
    • Beneke R, Pollmann C, Bleif I, et al. How anaerobic is the Wingate Anaerobic Test for humans? Eur J Appl Physiol 2002;87:388-92.
    • (2002) Eur J Appl Physiol , vol.87 , pp. 388-392
    • Beneke, R.1    Pollmann, C.2    Bleif, I.3
  • 24
    • 0034740582 scopus 로고    scopus 로고
    • Evaluation of the Accusport lactate analyzer
    • Bishop D. Evaluation of the Accusport lactate analyzer. Int J Sports Med 2001;22:525-30.
    • (2001) Int J Sports Med , vol.22 , pp. 525-530
    • Bishop, D.1
  • 25
    • 0038458914 scopus 로고    scopus 로고
    • Warm up II. Performance changes following active warm up and how to structure the warm up
    • Bishop D. Warm up II. Performance changes following active warm up and how to structure the warm up. Sports Med 2003;33:483-98.
    • (2003) Sports Med , vol.33 , pp. 483-498
    • Bishop, D.1
  • 28
    • 26844453717 scopus 로고    scopus 로고
    • Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T
    • Hassan MA, Ketat AF. Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T. BMC Pharmacol 2005;6:5-10.
    • (2005) BMC Pharmacol , vol.6 , pp. 5-10
    • Hassan, M.A.1    Ketat, A.F.2
  • 29
    • 29544452788 scopus 로고    scopus 로고
    • Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors
    • Jackson G. Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. Am J Cardiol 2005;96:32-6M.
    • (2005) Am J Cardiol , vol.96
    • Jackson, G.1
  • 30
    • 0141505057 scopus 로고    scopus 로고
    • Abdollahi M, Chan TS, Subrahmanyam V, et al. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenosis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem 2003;252:205-11.
    • Abdollahi M, Chan TS, Subrahmanyam V, et al. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenosis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem 2003;252:205-11.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.